Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment

References

• Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, et al. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 2011;81:167–74.
   PubMed Web of Science ®Google Scholar
• Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2012;84:449–55.
   PubMed Web of Science ®Google Scholar
• Knausl B, Lutgendorf-Caucig C, Hopfgartner J, Dieckmann K, Kurch L, Pelz T, et al. Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy? Strahlenther Onkol 2013;189:54–61.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af Rosenschöld P, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 2013;24:2113–18.
   PubMed Web of Science ®Google Scholar
• Dowdell S, Grassberger C, Sharp GC, Paganetti H. Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters. Phys Med Biol 2013;58:4137–56.
   PubMed Web of Science ®Google Scholar
• ICRUI. CRU Report 78: Prescribing, recording, and reporting proton-beam therapy. J ICRU 2007;7:1–210.
   Google Scholar
• Bortfeld T, Jokivarsi K, Goitein M, Kung J, Jiang SB. Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol 2002;47:2203–20.
   PubMed Web of Science ®Google Scholar
• Phillips MH, Pedroni E, Blattmann H, Boehringer T, Coray A, Scheib S. Effects of respiratory motion on dose uniformity with a charged particle scanning method. Phys Med Biol 1992;37:223–34.
   PubMed Web of Science ®Google Scholar
• Seco J, Robertson D, Trofimov A, Paganetti H. Breathing interplay effects during proton beam scanning: simulation and statistical analysis. Phys Med Biol 2009;54:N283–94.
   PubMed Web of Science ®Google Scholar
• Zenklusen SM, Pedroni E, Meer D. A study on repainting strategies for treating moderately moving targets with proton pencil beam scanning at the new Gantry 2 at PSI. Phys Med Biol 2010;55:5103–21.
   PubMed Web of Science ®Google Scholar
• Bassler N, Jakel O, Sondergaard CS, Petersen JB. Dose- and LET-painting with particle therapy. Acta Oncol 2010;49:1170–6.
   PubMed Web of Science ®Google Scholar
• Zeng C, Plastaras JP, Tochner ZA, White BM, Hill-Kayser CE, Hahn SM, et al. Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning. Phys Med Biol 2015;60:3013–29.
   PubMed Web of Science ®Google Scholar
• Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2014;89:49–58.
   PubMed Web of Science ®Google Scholar
• Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiation Oncology Biol Phys 2014;89:854–62.
   PubMed Web of Science ®Google Scholar
• Paganetti H, editor. Proton Therapy Physics. Boca Raton: CRC Press; 2011.
   Google Scholar
• Goitein M. Calculation of the uncertainty in the dose delivered during radiation therapy. Med Phys 1985;12:608–12.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af Rosenschold P, Petersen PM, et al. Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy. Radiother Oncol 2014;110:441–7.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987–98.
   PubMed Web of Science ®Google Scholar
• van Nimwegen FA, Schaapveld M, Cutter DJ, Janus CPM, Krol ADG, Hauptmann M, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 2015;34:235–43.
   PubMed Web of Science ®Google Scholar
• Pinnix C, Smith GL, Milgrom S, Osborne EM, Reddy RP, Akhtari M, et al. Preditors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2015;92:175–82.
   PubMed Web of Science ®Google Scholar
• Travis LB, Gospodarowica M, Curtis RE, Clarke EA, Andersson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002;94:182–92.
   PubMed Web of Science ®Google Scholar
• Nie K, Chuang C, Kirby N, Braunstein S, Pouliot J. Site-specific deformable imaging registration algorithm selection using patient-based simulated deformations. Med Phys 2013;40:041911.
   Google Scholar
• Graves YJ, Smith AA, Mcilvena D, Manilay Z, Lai YK, Rice R, et al. A deformable head and neck phantom with in-vivo dosimetry for adaptive radiotherapy quality assurance. Med Phys 2015;42:1490–7.
   PubMed Web of Science ®Google Scholar
• Kuo HC, Mah D, Chuang KS, Wu A, Hong L, Yaparpalvi R, et al. A method incorporating 4DCT data for evaluating the dosimetric effects of respiratory motion in single-arc IMAT. Phys Med Biol 2010;55:3479–97.
   PubMed Web of Science ®Google Scholar
• Grassberger C, Dowdell S, Lomax A, Sharp G, Shackleford J, Choi N, et al. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys 2013;86:380–6.
   PubMed Web of Science ®Google Scholar